Medications for opioid use disorder: finding the right care

Addiction Care · 4 min read · Updated November 13, 2026

Medications for opioid use disorder can be a central part of care. If you are looking for treatment, ask directly whether a program offers these medicines or connects people promptly with a qualified prescriber. A program’s name or description of “detox” does not answer that question.

Three established medication options

CDC identifies buprenorphine, methadone, and naltrexone as FDA-approved treatments for opioid use disorder. Buprenorphine and methadone can reduce cravings and withdrawal. Naltrexone blocks opioid effects. They work differently and have different requirements for starting treatment, so a clinician needs to assess which option fits an individual’s situation.

Do not try to start, switch, or restart these medicines using someone else’s prescription or an online dosing schedule. Tell the prescriber about recent opioid use, alcohol, sedatives, other medications, and any upcoming procedure. You can ask why a particular option is being recommended and what alternatives were considered.

Medication is treatment, not a test of commitment

CDC links medication treatment with lower overdose and mortality risk and advises against detoxification alone for opioid use disorder. It also states that declining counseling, or being unable to access it, should not delay medication. Counseling and practical support can still be valuable parts of a plan when they fit the person’s needs.

The CDC overview of treatment and recovery provides an accessible introduction to available services. When reading program websites, look for clear explanations of the treatment offered. If medication policies are vague, ask for clarification before making travel or payment arrangements.

Compare the practical demands

A treatment that is clinically appropriate also needs a realistic access plan. Ask the provider to walk you through the first appointment and a typical follow-up week. Confirm which parts happen in person, how refills or scheduled visits work, and whom to contact if a problem interrupts access.

• Can you provide or arrange the medication being discussed?
• How soon can a clinician assess me, and what should I bring?
• What appointment and medication costs should I confirm with my insurer?
• How do you help if work, transportation, disability, or caregiving affects attendance?
• How are pain treatment and other prescriptions coordinated?
• What is your approach if I return to use or miss an appointment?

Keep the answers from each provider together. A respectful explanation of options is more useful than a promise of a quick cure. Ask for clarification whenever a recommendation sounds like a fixed rule that has not considered your circumstances.

Plan for continuity and overdose safety

Before a hospital discharge, move, or change of program, ask who will continue prescribing and when the next appointment will occur. Confirm those details before the transition where possible. If you have already lost access, contact the clinical team promptly for instructions instead of improvising a replacement.

FDA recommends naloxone access for people prescribed opioid use disorder medicines and for people around someone at risk of overdose. Ask the clinician or pharmacist to explain how to use the product you receive. Naloxone is emergency overdose treatment; it serves a different purpose from ongoing opioid use disorder medication.

At follow-up, discuss benefits, side effects, access problems, and your goals. Decisions about continuing or changing medication should be shared with the prescriber. Addiction Care can help identify referral options, but it does not prescribe these medications or decide how long someone should take them.

← Explore more resources